SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
S-3/A	Pre-effective amendment to an S-3 filing	Oct 31, 2018	View HTML 0001193125-18-314121.pdf 0001193125-18-314121.rtf 0001193125-18-314121.xls
S-3/A	Pre-effective amendment to an S-3 filing	May 05, 2021	View HTML 0001193125-21-151688.pdf 0001193125-21-151688.rtf 0001193125-21-151688.xls
POS AM	Post-effective amendment to an S-Type filing	Jun 20, 2008	View HTML 0001193125-08-136862.pdf 0001193125-08-136862.rtf 0001193125-08-136862.xls
POS AM	Post-effective amendment to an S-Type filing	Jun 20, 2008	View HTML 0001193125-08-136863.pdf 0001193125-08-136863.rtf 0001193125-08-136863.xls
POS AM	Post-effective amendment to an S-Type filing	Jul 03, 2008	View HTML 0001193125-08-146757.pdf 0001193125-08-146757.rtf 0001193125-08-146757.xls
F-6 POS	Post-effective amendment to a previously filed F-6	Jun 11, 2008	View HTML 0001193805-08-001549.pdf 0001193805-08-001549.rtf
DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Oct 25, 2010	View HTML 0001193125-10-235158.pdf 0001193125-10-235158.rtf 0001193125-10-235158.xls
DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Oct 25, 2011	View HTML 0001193125-11-279773.pdf 0001193125-11-279773.rtf 0001193125-11-279773.xls
DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Oct 25, 2012	View HTML 0001193125-12-435039.pdf 0001193125-12-435039.rtf 0001193125-12-435039.xls
DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	May 02, 2008	View HTML 0001193125-08-100478.pdf 0001193125-08-100478.rtf 0001193125-08-100478.xls

Data provided by Kaleidoscope.